JP2010512339A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010512339A5 JP2010512339A5 JP2009540465A JP2009540465A JP2010512339A5 JP 2010512339 A5 JP2010512339 A5 JP 2010512339A5 JP 2009540465 A JP2009540465 A JP 2009540465A JP 2009540465 A JP2009540465 A JP 2009540465A JP 2010512339 A5 JP2010512339 A5 JP 2010512339A5
- Authority
- JP
- Japan
- Prior art keywords
- medicament
- compound according
- manufacture
- mammal
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 3
- 241000124008 Mammalia Species 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 208000020401 Depressive disease Diseases 0.000 claims 1
- 102000018899 Glutamate Receptors Human genes 0.000 claims 1
- 108010027915 Glutamate Receptors Proteins 0.000 claims 1
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 201000000980 schizophrenia Diseases 0.000 claims 1
Claims (7)
- 次式
- 次式
- 医薬として使用するための請求項１に記載の化合物。
- パーキンソン病を治療するための医薬の製造のための、請求項１に記載の化合物の使用。
- うつ病を治療するための医薬の製造のための、請求項１に記載の化合物の使用。
- 統合失調症を治療するための医薬の製造のための、請求項１に記載の化合物の使用。
- かかる治療を必要とする哺乳動物に有効量の請求項１に記載の化合物を投与することを含んでなる、哺乳動物におけるグルタミン酸受容体の機能を増強する方法。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06380319 | 2006-12-11 | ||
| US88856207P | 2007-02-07 | 2007-02-07 | |
| PCT/US2007/086567 WO2008073789A1 (en) | 2006-12-11 | 2007-12-06 | Ampa receptor potentiators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010512339A JP2010512339A (ja) | 2010-04-22 |
| JP2010512339A5 true JP2010512339A5 (ja) | 2011-01-27 |
Family
ID=39272878
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009540465A Withdrawn JP2010512339A (ja) | 2006-12-11 | 2007-12-06 | Ａｍｐａ受容体増強剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8097652B2 (ja) |
| EP (1) | EP2102153A1 (ja) |
| JP (1) | JP2010512339A (ja) |
| KR (1) | KR20090082278A (ja) |
| CN (1) | CN101541741A (ja) |
| AU (1) | AU2007333247B2 (ja) |
| CA (1) | CA2672462A1 (ja) |
| EA (1) | EA015600B1 (ja) |
| MX (1) | MX2009006243A (ja) |
| WO (1) | WO2008073789A1 (ja) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY33551A (es) | 2010-08-10 | 2012-03-30 | Takeda Pharmaceutical | Compuesto heterocíclico y su uso |
| EP2694472B1 (en) | 2011-04-05 | 2020-03-11 | Takeda Pharmaceutical Company Limited | Sulfonamide derivative and use thereof |
| US20210009613A1 (en) * | 2017-12-12 | 2021-01-14 | Shenzhen Targetrx, Inc. | Arylphosphine oxides for inhibiting kinase activity |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9702194D0 (en) * | 1997-02-04 | 1997-03-26 | Lilly Co Eli | Sulphonide derivatives |
| PL358180A1 (en) * | 2000-05-19 | 2004-08-09 | Eli Lilly And Company | Sulfonamide derivatives |
-
2007
- 2007-12-06 AU AU2007333247A patent/AU2007333247B2/en not_active Ceased
- 2007-12-06 WO PCT/US2007/086567 patent/WO2008073789A1/en active Application Filing
- 2007-12-06 EP EP07854979A patent/EP2102153A1/en not_active Withdrawn
- 2007-12-06 KR KR1020097011988A patent/KR20090082278A/ko not_active Application Discontinuation
- 2007-12-06 CA CA002672462A patent/CA2672462A1/en not_active Abandoned
- 2007-12-06 JP JP2009540465A patent/JP2010512339A/ja not_active Withdrawn
- 2007-12-06 MX MX2009006243A patent/MX2009006243A/es not_active Application Discontinuation
- 2007-12-06 US US12/517,431 patent/US8097652B2/en not_active Expired - Fee Related
- 2007-12-06 EA EA200970573A patent/EA015600B1/ru not_active IP Right Cessation
- 2007-12-06 CN CNA200780043800XA patent/CN101541741A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009502743A5 (ja) | ||
| JP2009545527A5 (ja) | ||
| JP2013525444A5 (ja) | ||
| JP2018518537A5 (ja) | ||
| JP2012532874A5 (ja) | ||
| JP2008513510A5 (ja) | ||
| JP2007145875A5 (ja) | ||
| JP2015501783A5 (ja) | ||
| JP2010529118A5 (ja) | ||
| JP2013542247A5 (ja) | ||
| JP2011518833A5 (ja) | ||
| JP2009502793A5 (ja) | ||
| JP2014507446A5 (ja) | ||
| JP2006515626A5 (ja) | ||
| JP2008517059A5 (ja) | ||
| FI2291080T5 (fi) | Uusia sfingosiinifosfaattireseptorimodulaattoreita | |
| JP2006514012A5 (ja) | ||
| JP2006526031A5 (ja) | ||
| JP2013522326A5 (ja) | ||
| JP2014515013A5 (ja) | ||
| JP2007522220A5 (ja) | ||
| IL208982B (en) | A preparation containing baclofen or a salt, derivative or delayed release formulation thereof for use in the treatment of Alzheimer's disease | |
| JP2013509429A5 (ja) | ||
| JP2008500378A5 (ja) | ||
| JP2011505356A5 (ja) |